Zymeworks Inc. (ZYME) Balance Sheet

NASDAQ: ZYMEAssets, liabilities, debt and equity over 10 years.

ZYME balance sheet, 2025

December 31, 2025 · U.S. dollars

$346.5M assets = $78.0M liabilities + $268.5M equity

What it owns$346.5MCash & ST investments: $228.8M (66.0%)Receivables: $4.6M (1.3%)PP&E: $31.2M (9.0%)Goodwill & intangibles: $13.37B (3,857.1%)Goodwill & intangibles$13.37B · 3,857%LT investments: $41.8M (12.1%)=How it is financed$346.5MCurrent liabilities: $42.3M (12.2%)Other LT liabilities: $35.7M (10.3%)Shareholders’ equity: $268.5M (77.5%)

Both columns are drawn to the same scale: what ZYME owns equals what it owes plus shareholders’ equity. Hover a block for its value.

ZYME financial health

Current ratio5.52
Comfortable · current assets cover current liabilities 5.52×
Debt / equity0.07
Low leverage · $0.07 of debt for each $1 of equity
Equity / assets77.5%
Equity-funded · of assets funded by shareholders
Cash / debt1,252.5%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles3,857.1%
Mostly intangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

ZYME balance sheet trends, 2016–2025

Zymeworks Inc. balance sheet trends
MetricTrendThenLatestChange
Total assets$94.0M2016$346.5M2025+15.6%/yr
Total liabilities$85.0M2016$78.0M2025−0.9%/yr
Shareholders’ equity$9.0M2016$268.5M2025+45.8%/yr
Cash & short-term investments$40.3M2016$228.8M2025+21.3%/yr
Total debt$4.4M2016$18.3M2025+17.1%/yr
Net cash (debt)$35.8M2016$210.5M2025+$174.7M
Working capital$29.9M2016$191.1M2025+$161.2M
Book value per share$0.462016$3.562025+25.6%/yr
Current ratio2.8120165.522025+2.71
Debt / equity0.4920160.072025−0.42
Shares outstanding19.7M201675.3M2025+16.1%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

ZYME assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

ZYME liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

ZYME debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

ZYME balance sheet

Zymeworks Inc. annual balance sheet
2025202420232022202120202019201820172016
Assets
Cash & short-term investments$228.8M$225.8M$374.3M$492.2M$252.6M$426.4M$298.9M$200.2M$87.8M$40.3M
Cash & equivalents$41.2M$66.1M$157.6M$400.9M$201.9M$242.0M$128.5M$42.2M$35.9M$16.4M
Short-term investments$187.6M$159.7M$216.8M$91.3M$50.7M$184.3M$170.5M$158.0M$51.9M$23.8M
Receivables$4.6M$55.8M$19.5M$33.4M$15.6M$15.3M$2.2M$358,000$2.3M$4.3M
Inventory$0$0$1$0$0$0$1$1$1$1
Other current assets$0$18.9M$19.1M$19.1M$20.0M$13.4M$10.7M$3.8M$2.2M$1.9M
Total current assets$233.4M$300.5M$412.9M$544.7M$288.2M$455.1M$311.8M$204.4M$92.3M$46.5M
Property, plant & equipment (net)$31.2M$34.3M$37.5M$47.6M$49.8M$17.6M$16.5M$6.5M$7.2M$6.7M
Goodwill & intangible assets$13.37B$16.6M$37.3M$38.4M$33.5M$34.9M$35.7M$32.0M$31.2M$32.6M
Long-term investments$41.8M$98.4M$82.1M$886,000$886,000$25.9M$0$0$0$0
Other non-current assets$0$13.3M$11.0M$17.1M$16.8M$4.8M$4.2M$1.5M$1.3M$8.1M
Total assets$346.5M$463.1M$580.9M$648.7M$389.1M$538.4M$368.2M$244.4M$132.0M$94.0M
Liabilities
Accounts payable$4.4M$3.9M$6.2M$7.9M$5.2M$6.2M$5.3M$2.6M$1.7M$3.0M
Short-term debt$3.5M$2.7M$4.3M$3.3M$1.3M$2.7M$1.3M$15,000$10,000$8,000
Deferred revenue$2.4M$25.6M$3.7M$2.4M$57.6M$37.4M$30.3M$3.5M$7.5M$6.8M
Total current liabilities$42.3M$88.3M$55.8M$95.6M$71.9M$85.7M$82.6M$30.0M$14.7M$16.6M
Long-term debt$0$0$0$0$0$0$46,000$42,000$52,000$4.4M
Lease obligations$18.3M$18.5M$26.7M$28.1M$41.2M$8.6M$6.9M$57,000$62,000$8,000
Other long-term liabilities$35.7M$36.0M$60.3M$60.1M$68.2M$42.8M$39.9M$33.8M$814,000$64.0M
Total liabilities$78.0M$124.3M$116.1M$155.8M$140.0M$128.5M$122.5M$63.9M$15.5M$85.0M
Shareholders' equity
Common stock & paid-in capital$1.11B$1.02B$1.01B$906.8M$741.1M$724.2M$450.2M$320.1M$223.0M$106.6M
Retained earnings (deficit)−$953.2M−$830.3M−$677.4M−$558.8M−$683.1M−$471.3M−$290.7M−$145.3M−$108.7M−$97.8M
Accumulated other comprehensive income−$6.1M−$7.0M−$6.6M−$6.7M−$6.7M−$6.7M−$6.7M−$6.7M−$6.7M−$6.7M
Total shareholders' equity$268.5M$338.8M$464.8M$493.0M$249.1M$409.9M$245.7M−$145.3M$116.4M$9.0M
Key figures
Total debt$18.3M$18.5M$26.7M$28.1M$32.3M$8.6M$6.9M$57,000$62,000$4.4M
Net cash (debt)$210.5M$207.3M$347.6M$464.1M$220.3M$417.7M$292.0M$200.1M$87.7M$35.8M
Working capital$191.1M$212.2M$357.2M$449.1M$216.4M$369.4M$229.3M$174.4M$77.7M$29.9M
Tangible book value−$13.10B$322.2M$427.5M$454.6M$215.6M$375.0M$210.0M−$177.3M$85.3M−$23.6M
Book value per share$3.56$4.46$6.75$7.55$4.78$8.14$6.46−$4.99$5.46$0.46
Shares outstanding75.3M75.9M68.9M65.2M52.1M50.4M38.0M29.1M21.3M19.7M
Current ratio5.523.407.415.704.015.313.786.826.302.81
Quick ratio5.523.197.065.503.735.163.656.696.152.69
Debt / equity0.070.050.060.060.130.020.03—0.000.49
Equity / assets77.5%73.2%80.0%76.0%64.0%76.1%66.7%−59.4%88.2%9.6%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 2, 2026); data from EODHD.

ZYME financial position

At the end of fiscal 2025 (December 31, 2025), Zymeworks had total assets of $346.5 million (down 25.2% from a year earlier), total liabilities of $78.0 million and shareholders' equity of $268.5 million. It held $228.8 million in cash and short-term investments against $18.3 million of debt, a net cash position of $210.5 million. Its current ratio was 5.52. In the latest quarter (ended June 30, 2026) total assets were $397.0 million and equity $80.4 million.

Related: ZYME income statement, ZYME cash flow statement, ZYME key metrics. See the ZYME stock overview for the latest quote and news.

ZYME balance sheet FAQ

What are Zymeworks's total assets?

Zymeworks reported total assets of $346.5 million at the end of fiscal 2025 (December 31, 2025), compared with $463.1 million a year earlier.

How much debt does Zymeworks have?

Zymeworks had $18.3 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.07.

How much cash does Zymeworks have?

Zymeworks held $228.8 million in cash and short-term investments at the end of fiscal 2025; with $18.3 million of debt that is net cash of $210.5 million.

What is Zymeworks's book value?

Zymeworks's shareholders' equity (book value) was $268.5 million at the end of fiscal 2025, or $3.56 per share.

What is Zymeworks's current ratio?

Zymeworks had current assets of $233.4 million and current liabilities of $42.3 million, a current ratio of 5.52 (it can cover its short-term obligations).

How much goodwill does Zymeworks have?

Zymeworks carried $13.4 billion of goodwill and intangible assets, 3,857.1% of total assets, at the end of fiscal 2025.

Biotechnology: balance sheet